Compagnie Financiere Richemont (CFRUY)
(Delayed Data from OTC)
$13.46 USD
-0.74 (-5.21%)
Updated Sep 20, 2024 03:59 PM ET
4-Sell of 5 4
D Value C Growth B Momentum C VGM
Income Statements
Fiscal Year end for Compagnie Financiere Richemont AG falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 22,375 | 20,779 | 22,298 | 15,352 | 15,830 |
Cost Of Goods | NA | 6,495 | 8,317 | 6,171 | 6,256 |
Gross Profit | NA | 14,284 | 13,981 | 9,182 | 9,574 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 9,045 | 10,041 | 7,455 | 7,886 |
Income After Depreciation & Amortization | 0 | 5,239 | 3,941 | 1,726 | 1,688 |
Non-Operating Income | NA | 337 | 170 | 388 | 205 |
Interest Expense | NA | 622 | 1,115 | 345 | 560 |
Pretax Income | NA | 4,955 | 2,996 | 1,770 | 1,332 |
Income Taxes | NA | 882 | 579 | 264 | 297 |
Minority Interest | NA | 0 | 6 | -14 | -2 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 4,143 | 4,073 | 2,417 | 1,506 | 1,035 |
Extras & Discontinued Operations | -1,579 | -3,759 | 0 | 0 | 0 |
Net Income (GAAP) | 2,564 | 313 | 2,411 | 1,520 | 1,037 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 6,004 | 4,936 | 2,730 | 2,659 |
Depreciation & Amortization (Cash Flow) | NA | 764 | 995 | 1,003 | 972 |
Income After Depreciation & Amortization | 0 | 5,239 | 3,941 | 1,726 | 1,688 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 5,794.00 | 5,690.91 | 5,743.56 | 5,666.00 | 5,668.29 |
Diluted EPS Before Non-Recurring Items | 0.72 | 0.73 | 0.42 | 0.27 | 0.18 |
Diluted Net EPS (GAAP) | 0.44 | 0.06 | 0.42 | 0.27 | 0.18 |
Fiscal Year end for Compagnie Financiere Richemont AG falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |